[go: up one dir, main page]

DE69302897D1 - Liposomale itraconazol formulierungen - Google Patents

Liposomale itraconazol formulierungen

Info

Publication number
DE69302897D1
DE69302897D1 DE69302897T DE69302897T DE69302897D1 DE 69302897 D1 DE69302897 D1 DE 69302897D1 DE 69302897 T DE69302897 T DE 69302897T DE 69302897 T DE69302897 T DE 69302897T DE 69302897 D1 DE69302897 D1 DE 69302897D1
Authority
DE
Germany
Prior art keywords
liposomal
itraconazole
itraconazole formulations
phospholipid
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69302897T
Other languages
English (en)
Other versions
DE69302897T2 (de
Inventor
Giovanni Lucchetti
Giuseppe Assogna
Pietro Bagnato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Cilag SpA
Original Assignee
Janssen Cilag SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Cilag SpA filed Critical Janssen Cilag SpA
Application granted granted Critical
Publication of DE69302897D1 publication Critical patent/DE69302897D1/de
Publication of DE69302897T2 publication Critical patent/DE69302897T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69302897T 1992-02-12 1993-02-04 Liposomale itraconazol formulierungen Expired - Fee Related DE69302897T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92200397 1992-02-12
PCT/EP1993/000273 WO1993015719A1 (en) 1992-02-12 1993-02-04 Liposomal itraconazole formulations

Publications (2)

Publication Number Publication Date
DE69302897D1 true DE69302897D1 (de) 1996-07-04
DE69302897T2 DE69302897T2 (de) 1996-09-26

Family

ID=8210419

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69302897T Expired - Fee Related DE69302897T2 (de) 1992-02-12 1993-02-04 Liposomale itraconazol formulierungen

Country Status (17)

Country Link
EP (1) EP0625899B1 (de)
JP (1) JPH07503953A (de)
KR (1) KR940703651A (de)
CN (1) CN1076614A (de)
AT (1) ATE138561T1 (de)
AU (1) AU661754B2 (de)
CA (1) CA2129828A1 (de)
DE (1) DE69302897T2 (de)
DK (1) DK0625899T3 (de)
ES (1) ES2091019T3 (de)
GR (1) GR3020695T3 (de)
IL (1) IL104689A (de)
MX (1) MX9300708A (de)
MY (1) MY131524A (de)
TW (1) TW267103B (de)
WO (1) WO1993015719A1 (de)
ZA (1) ZA93955B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438601B (en) * 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
DE69808670T2 (de) 1997-12-31 2003-07-03 Choongwae Pharma Corp., Seoul/Soul Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
CA2362728C (en) 1999-03-24 2009-06-23 Fmc Corporation Improved aqueous solubility pharmaceutical formulations
KR100331529B1 (ko) * 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
KR100388605B1 (ko) * 2000-06-13 2003-06-25 코오롱제약주식회사 용해도 및 용해속도가 향상된 이트라코나졸의 액상 조성물 및 이를 이용한 이트라코나졸 제제와 그 제조방법
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
CU23175A1 (es) * 2000-07-17 2006-09-22 Ct De Investigacion Y Desarrol Formulacion liposomica de propionato de clobetasol
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
WO2004108114A2 (en) * 2003-03-31 2004-12-16 Dinesh Shantilal Patel Anti-fungal composition and a process for its manufacture
KR100712734B1 (ko) 2005-05-31 2007-05-04 에이엔에이치 케어연구소(주) 이트라코나졸을 함유하는 피부외용제
KR100970911B1 (ko) * 2007-12-13 2010-07-20 재단법인서울대학교산학협력재단 트리아졸계 항진균제를 함유하는 반고형 외용제 및 이의 제조방법
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
WO2009088959A1 (en) * 2008-01-04 2009-07-16 Brian Charles Keller Enhanced delivery of antifungal agents
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
EP3052487B1 (de) 2013-10-03 2018-09-05 Dow Pharmaceutical Sciences, Inc. Stabilisierte efinaconazolzusammensetzungen
KR102612453B1 (ko) * 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 항­감염 방법,조성물,및 장치
EP3669191A4 (de) * 2017-08-20 2021-04-14 University of Connecticut Azol-analoga und verfahren zur verwendung davon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
DE3600947A1 (de) * 1986-01-15 1987-07-16 Kali Chemie Pharma Gmbh Antimykotische emulsionen
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
CA1336761C (en) * 1987-10-19 1995-08-22 Christine E. Swenson Aqueous preparation of liposomal composition
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators

Also Published As

Publication number Publication date
DK0625899T3 (da) 1996-06-17
EP0625899A1 (de) 1994-11-30
DE69302897T2 (de) 1996-09-26
KR940703651A (ko) 1994-12-12
ZA93955B (en) 1994-08-11
TW267103B (de) 1996-01-01
WO1993015719A1 (en) 1993-08-19
JPH07503953A (ja) 1995-04-27
CN1076614A (zh) 1993-09-29
AU661754B2 (en) 1995-08-03
CA2129828A1 (en) 1993-08-19
AU3453593A (en) 1993-09-03
EP0625899B1 (de) 1996-05-29
ES2091019T3 (es) 1996-10-16
GR3020695T3 (en) 1996-10-31
MX9300708A (es) 1994-07-29
ATE138561T1 (de) 1996-06-15
MY131524A (en) 2007-08-30
IL104689A0 (en) 1993-06-10
IL104689A (en) 1996-12-05

Similar Documents

Publication Publication Date Title
DE69302897D1 (de) Liposomale itraconazol formulierungen
ATE104845T1 (de) Tocopherolsorbat und entzuendungshemmende wirkstoffe enthaltende lichtschutzmittel.
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
AU2408388A (en) Photoprotection compositions comprising tocopherol sorbate
GR3023825T3 (en) Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
NO910340L (no) Topiske preparater for behandling av menneskenegler.
CA2099188A1 (en) Use of a cosmetic composition
ATE321534T1 (de) Verbesserte liposomale formulierung
ATE137959T1 (de) Liposomale piroxycam formulierung
DE69005410D1 (de) Verfahren zur Herstellung einer wässrigen Dispersion von Lipidvesikeln sowie Zusammensetzung auf Basis der so hergestellten Dispersion.
IT1119948B (it) Tensioattivi cationici particolarmente per cosmetici e procedimento per la loro preparazione
DE69207777D1 (de) Körperpflegemittel
IT1255762B (it) Formulazioni liposomiche di piroxicam.
FI951092L (fi) Fluoreseiinijohdannaisten stabiilit korkeakonsentroidut valmisteet
KR950700743A (ko) 프로스타사이클린류를 활성성분으로서 함유하는 외용 피부치료제 조성물(dermatologic preparation composition containing prostacyclin as active ingredient)
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO178782C (no) Fremgangsmåte for fremstilling av et farmasöytisk akseptabelt gelpreparat
FI915565L (fi) Menetelmä paikalliseen käyttöön tarkoitettujen farmaseuttisten koostumusten valmistamiseksi
NO169071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-3-(1h-1,2,4-triazol-1-ylmetyl)-5-substituerte-2-metylisoxazolidiner
TH13522A (th) การเข้าสูตรไลโพโซมับ อิทราโคนาโซล
IT8225072A0 (it) Composizioni a base di estratto di mirtillo per uso terapeutico e processo per la loro preparazione.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee